small molecule

EPIDIOLEX

CANNABIDIOL

Loss of exclusivityMarch 2041latest FDA-listed patent expiry

CompanyJAZZ PHARMACEUTICALS RESEARCH UK LTD

Drug detail

Brand name	EPIDIOLEX
Active ingredient	CANNABIDIOL
Strength	100MG/ML
Dosage form	SOLUTION
Route	ORAL
Modality	Small molecule
FDA approval	September 2018
Marketing status	RX

Listed patents

Patent	Expires	Type
11406623	March 2041	use U-3233
11160795	March 2041	use U-3233
12102619	March 2041	use U-3233
11865102	April 2039	substance, product
11207292	April 2039	substance
11065209	October 2035	use U-3071
10918608	October 2035	use U-3073
11400055	October 2035	use U-3071
11096905	October 2035	substance, product
10709671	June 2035	use U-2862
10709674	June 2035	use U-2780
9956184	June 2035	use U-2424
11963937	June 2035	use U-2781
9956185	June 2035	use U-2425
12064399	June 2035	use U-3989
11766411	June 2035	use U-2781
11154516	June 2035	use U-3236
10849860	June 2035	use U-2454
11311498	June 2035	use U-3376
10966939	June 2035	product
11446258	June 2035	use U-3071
11701330	June 2035	use U-2781
9956186	June 2035	use U-2426
10709673	June 2035	product
10092525	June 2035	use U-2427
9956183	June 2035	use U-2423
9949937	June 2035	use U-2421
10111840	June 2035	use U-2442
10137095	June 2035	use U-2455
11633369	June 2035	product
10603288	June 2035	use U-2783
11357741	June 2035	use U-2862

Regulatory exclusivity

Code	Expires
ODE-326	July 2027
ODE-332	July 2027
M-270	October 2026

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.